Rapid. Reliable. Secure
ICH Q1A(R2)‑aligned programs for DNA/RNA, ASO, siRNA, and sgRNA — including accelerated, intermediate, and long‑term studies, stress testing, and sodium content trending with stability‑indicating methods.
We design and execute ICH Q1A(R2)‑aligned stability programs for DNA/RNA, ASO, siRNA, and sgRNA. Studies include accelerated, intermediate, and long‑term storage, with photostability and freeze‑thaw as needed—plus trending plots and a final stability summary.
Pull schedules and attributes are tailored to your formulation and intended use, with optional sodium content trending across pulls.
✓ = typical pull point; schedules customizable per protocol. Sodium content may be trended by ion chromatography or flame photometry and reported at each pull.
✓ = typical pull point; schedules customizable per protocol. Additional pulls can be defined as needed. Sodium content can be trended and reported at each pull as requested.
Identity, purity/impurities, residuals, sodium content, and safety testing with signed CoA.
Scouting → optimization → transfer → ICH Q2(R2) validation with protocols, raw data, and reports.
RUO to GMP‑aligned oligos; HPLC/PAGE, diafiltration; broad chemistry & conjugation support.
We can add custom attributes (e.g., buffer ions, counter‑ions, conjugate ratio) to your study plan.
Share your formulation, storage conditions, and target shelf‑life — our team will design a fit‑for‑purpose protocol.
JavaScript is disabled. The Email button above will open your email client to contact info@biosyn.com.
Email: info@biosyn.com • Phone: +1 (972) 420‑8505
Trusted by biotech leaders worldwide for over 45 years of delivering high quality, fast and scalable synthetic biology solutions.